Monte Rosa Therapeutics, Inc. (GLUE) SEC filings

GLUE SEC filings moved a median of -0.68% by the close. GLUE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GLUE overview →

59 measured GLUE SEC filing events.

Where these GLUE SEC filings landedvs 59 measured GLUE SEC filing reactions
GLUE SEC filingMiddle 50% · -3.07% to +4.28%Zero: 0.00%Median: -0.68%Median -0.68%-6.00%0+6.00%
Middle 50% of GLUE SEC filing reactions-3.07% to +4.28%
Median reaction (to close)-0.68%
Measured reactions59
Point-in-time · zero look-ahead

Half of the 59 GLUE SEC filing events with a measured close landed between -3.07% and +4.28%; 46% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Monte Rosa Therapeutics, For: Oct 01SEC filing · Form 8-K-3.88%-6.71%
Form 8-K Monte Rosa Therapeutics, For: Sep 08SEC filing · Form 8-K+0.22%+5.31%
Form 10-Q Monte Rosa Therapeutics, For: Jun 30SEC filing · Form 10-Q+1.02%+0.58%
Form 8-K Monte Rosa Therapeutics, For: Aug 06SEC filing · Form 8-K+1.02%+0.58%
Form 8-K Monte Rosa Therapeutics, For: Jun 11SEC filing · Form 8-K+2.18%+5.96%
Form 10-Q Monte Rosa Therapeutics, For: Mar 31SEC filing · Form 10-Q-0.15%-2.17%
Form 8-K Monte Rosa Therapeutics, For: May 07SEC filing · Form 8-K-0.15%-2.17%
Form ARS Monte Rosa Therapeutics, For: Dec 31SEC filing · Form ARS+0.96%+1.92%
Form DEF 14A Monte Rosa Therapeutics, For: Apr 29SEC filing · Form DEF+0.96%+1.92%
Form DEFA14A Monte Rosa Therapeutics,SEC filing · Form DEFA14A+0.96%+1.92%
Form S-8 Monte Rosa Therapeutics,SEC filing · Form S-8+0.06%-0.06%
Form 10-K Monte Rosa Therapeutics, For: Dec 31SEC filing · Form 10-K+1.92%-0.68%
Form 8-K Monte Rosa Therapeutics, For: Mar 17SEC filing · Form 8-K+1.92%-0.68%
Form S-3ASR Monte Rosa Therapeutics,SEC filing · Form S-3ASR+0.08%-1.33%
Form 8-K Monte Rosa Therapeutics, For: Feb 09SEC filing · Form 8-K-0.74%-3.71%
Form 8-K Monte Rosa Therapeutics, For: Jan 08SEC filing · Form 8-K+1.31%-1.41%
Form 8-K Monte Rosa Therapeutics, For: Jan 07SEC filing · Form 8-K+6.52%+6.06%
Form 8-K Monte Rosa Therapeutics, For: Dec 16SEC filing · Form 8-K+6.55%+5.78%
Form 10-Q Monte Rosa Therapeutics, For: Sep 30SEC filing · Form 10-Q-0.04%+4.92%
Form 8-K Monte Rosa Therapeutics, For: Nov 06SEC filing · Form 8-K-0.04%+4.92%
Form 8-K Monte Rosa Therapeutics, For: Sep 15SEC filing · Form 8-K-3.27%-3.08%
Form 10-Q Monte Rosa Therapeutics, For: Jun 30SEC filing · Form 10-Q-1.95%-3.20%
Form 8-K Monte Rosa Therapeutics, For: Aug 07SEC filing · Form 8-K-1.95%-3.20%
Form 8-K Monte Rosa Therapeutics, For: Jun 13SEC filing · Form 8-K-3.19%-3.79%
Form 10-Q Monte Rosa Therapeutics, For: Mar 31SEC filing · Form 10-Q-5.59%-5.59%
Form 8-K Monte Rosa Therapeutics, For: May 08SEC filing · Form 8-K-5.59%-5.59%
Form ARS Monte Rosa Therapeutics, For: Dec 31SEC filing · Form ARS+0.10%-1.98%
Form DEF 14A Monte Rosa Therapeutics, For: Apr 25SEC filing · Form DEF+0.10%-1.98%
Form DEFA14A Monte Rosa Therapeutics,SEC filing · Form DEFA14A+0.10%-1.98%
Form EFFECT Monte Rosa Therapeutics,SEC filing · Form EFFECT-1.31%-3.06%
Form 10-K Monte Rosa Therapeutics, For: Dec 31SEC filing · Form 10-K-1.07%+9.29%
Form 8-K Monte Rosa Therapeutics, For: Mar 20SEC filing · Form 8-K-1.07%+9.29%
Form S-3 Monte Rosa Therapeutics,SEC filing · Form S-3-1.81%+6.65%
Form S-8 Monte Rosa Therapeutics,SEC filing · Form S-8-1.07%+9.29%
Form 8-K Monte Rosa Therapeutics, For: Jan 10SEC filing · Form 8-K-1.38%-1.89%
Form 8-K Monte Rosa Therapeutics, For: Dec 11SEC filing · Form 8-K+3.69%-3.94%
Form 8-K Monte Rosa Therapeutics, For: Dec 05SEC filing · Form 8-K+2.24%-3.60%
Form 10-Q Monte Rosa Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.74%+0.74%
Form 8-K Monte Rosa Therapeutics, For: Nov 07SEC filing · Form 8-K+0.74%+0.74%
Form 8-K Monte Rosa Therapeutics, For: Oct 25SEC filing · Form 8-K-0.16%+48.13%
Form 10-Q Monte Rosa Therapeutics, For: Jun 30SEC filing · Form 10-Q-1.82%+3.65%
Form 8-K Monte Rosa Therapeutics, For: Aug 08SEC filing · Form 8-K-1.82%+3.65%
Form 8-K Monte Rosa Therapeutics, For: Jun 27SEC filing · Form 8-K+0.00%-8.40%
Form 8-K Monte Rosa Therapeutics, For: Jun 12SEC filing · Form 8-K+0.24%-3.37%
Form 8-K Monte Rosa Therapeutics, For: May 28SEC filing · Form 8-K+1.08%+1.73%
Form 8-K Monte Rosa Therapeutics, For: May 15SEC filing · Form 8-K-0.28%-1.89%
Form 10-Q Monte Rosa Therapeutics, For: Mar 31SEC filing · Form 10-Q-0.10%-1.15%
Form 8-K Monte Rosa Therapeutics, For: May 09SEC filing · Form 8-K-0.10%-1.15%
Form 8-K Monte Rosa Therapeutics, For: Apr 29SEC filing · Form 8-K-3.01%-2.92%
Form ARS Monte Rosa Therapeutics, For: Dec 31SEC filing · Form ARS+0.00%+4.28%
Form DEF 14A Monte Rosa Therapeutics, For: Apr 26SEC filing · Form DEF+0.00%+4.28%
Form DEFA14A Monte Rosa Therapeutics,SEC filing · Form DEFA14A+0.00%+4.28%
Form 10-K Monte Rosa Therapeutics, For: Dec 31SEC filing · Form 10-K+0.00%-7.02%
Form 8-K Monte Rosa Therapeutics, For: Mar 14SEC filing · Form 8-K+0.00%-7.02%
Form S-8 Monte Rosa Therapeutics,SEC filing · Form S-8+0.00%+5.25%
Form 8-K Monte Rosa Therapeutics, For: Jan 08SEC filing · Form 8-K-4.52%+9.91%
Form 10-Q Monte Rosa Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.00%-2.73%
Form 8-K Monte Rosa Therapeutics, For: Nov 09SEC filing · Form 8-K+1.91%-10.08%
Form 8-K Monte Rosa Therapeutics, For: Oct 26SEC filing · Form 8-K-0.41%+12.55%
That’s how GLUE usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More GLUE: earnings → · analyst actions → · GLUE overview →